Fort Lauderdale, FL, Jan. 29, 2025 (GLOBE NEWSWIRE) — Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU), (the “Company”) today announced that it closed its initial public offering of 20,000,000 units at $10.00 per unit. The gross proceeds from the offering were $200 million before deducting underwriting discounts and estimated offering expenses. The units began trading on the Nasdaq Global Market (“Nasdaq“) under the ticker symbol “DMAAU” on January 28, 2025.
Source: Drugs Made In America Acquisition Corp. Announces Closing of 0,000,000 Initial Public Offering